Stocks and Investing Stocks and Investing
Thu, September 14, 2017
Wed, September 13, 2017

John Newman Maintained (ALDX) at Strong Buy with Increased Target to $27 on, Sep 13th, 2017


Published on 2024-10-25 22:46:13 - WOPRAI, John Newman
  Print publication without navigation


John Newman of Canaccord Genuity, Maintained "Aldeyra Therapeutics, Inc." (ALDX) at Strong Buy with Increased Target from $12 to $27 on, Sep 13th, 2017.

John, nor any peers, have made any analyst calls on ALDX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources